Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for influenza in United States

80 results

Sort By:

Opioid, HIV and Immune System

Study ID: NCT04304768
Start Date: 2020-11-18
End Date: 2025-05-31
Study Type

Interventional

Study Phase

Phase4

No. of Participants

300

Intervention / Treatment

Fluzone Quadrivalent

Sponsor

University of Miami

Source: clinicaltrials.gov

Share:
Add to list

Tell me the truth: verify, debunk, and disseminate

Study ID: NCT06417762
Start Date: 2024-07-02
End Date: 2028-04-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

1400

Intervention / Treatment

Science Communication Curriculum Cohort 1

Science communication curriculum Cohort 2

Science communication curriculum Cohort 3

Sponsor

University of Chicago

Source: clinicaltrials.gov

Share:
Add to list

Flu Infection at UPHS

Study ID: NCT06807840
Start Date: 2025-01-27
End Date: 2026-09-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

influenza virus infection

Sponsor

University of Pennsylvania

Source: clinicaltrials.gov

Share:
Add to list

The DETECT(Digital Engagement & Tracking for Early Control, & Treatment) Study

Study ID: NCT04336020
Start Date: 2020-03-24
End Date: 2025-04
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

100000

Intervention / Treatment
Sponsor

Scripps Translational Science Institute

Source: clinicaltrials.gov

Share:
Add to list

Respiratory Virus Sampling and Repository

Study ID: NCT05266222
Start Date: 2022-08-11
End Date: 2031-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

20000

Intervention / Treatment
Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Source: clinicaltrials.gov

Share:
Add to list

A/Texas Flu Challenge

Study ID: NCT06753474
Start Date: 2025-02-04
End Date: 2027-12
Study Type

Interventional

Study Phase

Phase1

No. of Participants

50

Intervention / Treatment

Influenza Virus influenza A H3N2 strain

Sponsor

Emory University

Source: clinicaltrials.gov

Share:
Add to list

A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1010 in Healthy Adults

Study ID: NCT05606965
Start Date: 2022-11-02
End Date: 2025-11-11
Study Type

Interventional

Study Phase

Phase2

No. of Participants

325

Intervention / Treatment

mRNA-1010

Egg-based Quadrivalent Influenza Vaccine

Adjuvanted Quadrivalent Influenza Vaccine

Inactivated Influenza Vaccine

mRNA-1345

mRNA-1045

Sponsor

ModernaTX, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Prostate Specific Membrane Antigen (PSMA) or (FACBC) PET/CT Site-Directed Therapy for Treatment of Prostate Cancer, Flu-BLAST-PC Study

Study ID: NCT04175431
Start Date: 2020-09-30
End Date: 2031-07-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

100

Intervention / Treatment

Positron Emission Tomography

Lymphadenectomy

Radiation Therapy

Abiraterone Acetate

Prednisone

Computed Tomography

Abiraterone

PSMA PET Scan

Sponsor

University of Washington

Source: clinicaltrials.gov

Share:
Add to list

Bone Marrow and Peripheral Blood Immune Responses Study

Study ID: NCT05616546
Start Date: 2023-10-16
End Date: 2029-12
Study Type

Interventional

Study Phase

Phase4

No. of Participants

90

Intervention / Treatment

Vaccine influence

Sponsor

Emory University

Source: clinicaltrials.gov

Share:
Add to list

SCIVAX: Biomarkers of Immune Dysfunction and Vaccine Responsiveness in Chronic SCI

Study ID: NCT05869968
Start Date: 2023-03-31
End Date: 2027-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

140

Intervention / Treatment
Sponsor

Northwell Health

Source: clinicaltrials.gov

Share:
Add to list